Special Focus Session

SF 15b - Update on interstitial lung disease

March 6, 14:00 - 15:30 CET

4 min
Chairperson's introduction
Anand Devaraj, London / United Kingdom
20 min
Interstitial lung abnormalities (ILAs): what are they, and what should we do?
Mariana Benegas Urteaga, Barcelona / Spain
  1. To understand the definition of ILAs.
  2. To appreciate how and when to report CTs with ILAs.
  3. To understand the clinical significance of ILAs.
20 min
CT imaging of connective tissue disease ILD
Lisa Jungblut, Zurich / Switzerland
  1. To understand the typical and atypical CT features of CTDs.
  2. To appreciate the clinical significance of CT markers of disease severity in CTD.
  3. To understand the impact of technological developments in CTD imaging with CT.
20 min
Imaging of pulmonary toxicity from systemic cancer therapy
Guillaume Chassagnon, Paris / France
  1. To appreciate the different patterns of pulmonary toxicity on CT.
  2. To be aware of key systemic cancer therapies that cause pulmonary toxicity.
  3. To develop knowledge on how to optimally report CT findings of pulmonary toxicity.
18 min
CT imaging of hypersensitivity pneumonitis
Judith Babar, Shelford / United Kingdom
  1. To be aware of the classifications of hypersensitivity pneumonitis and the role of imaging.
  2. To understand the important diagnostic and prognostic CT features of hypersensitivity pneumonitis.
8 min
Panel discussion: The link between ILAs and ILD